Company Profile
Curis Inc Stock Price, News & Analysis
- Ticker:
- CRIS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
4.41 USD (-2.97%)
Close
Last updated: August 6, 2026
19.6M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, CRIS closed down 2.97% at $4.41. No new same-company headline was identified in the current news window.
Company overview
Business overview
Curis is a biotechnology company focused on oncology and immune-modulating therapies. Its story has been shaped by a small pipeline and repeated efforts to create durable value.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Curis sits in specialty biotechnology.
Business Model Characteristics
The company depends on clinical data, strategic focus, and the ability to build a more durable oncology and immunology story.
Position Within the Biotechnology Landscape
Curis is a small-cap catalyst name whose valuation depends on development progress and strategic clarity.
Future catalysts
Curis’s catalysts are oncology and immunotherapy pipeline updates, plus any strategic step that clarifies what still has value. The company needs a cleaner development path to matter again.
Recent news
- 01
Curis Doses First Five Patients in TakeAim CLL Study
Source: Curis Inc
- 02
Curis Announces Positive Emavusertib Update
Source: Curis Inc
- 03
Curis Consents First Six Patients in TakeAim CLL Study
Source: Curis Inc
- 04
- 05
Curis Provides First Quarter 2026 Business Update
Source: Curis Inc
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Curis Inc (CRIS)?
Curis Inc (CRIS) most recently closed at 4.41 USD, a -2.97% move versus the previous session.
What is the market cap of Curis Inc (CRIS)?
Curis Inc currently has a market capitalization of 19.6M USD on BioPharmSignal.
What does Curis Inc do?
Curis is a biotechnology company focused on oncology and immune-modulating therapies. Its story has been shaped by a small pipeline and repeated efforts to create durable value.
On which exchange is CRIS stock listed?
Curis Inc (CRIS) is associated with NASDAQ, United States, Biopharma.
What is Curis?
Curis’s catalysts are oncology and immunotherapy pipeline updates, plus any strategic step that clarifies what still has value.
Which conditions is Curis Inc targeting with Curis?
Curis Inc is associated with oncology based on its company overview and current catalyst commentary.
How does Curis Inc describe recent progress with Curis?
Curis’s catalysts are oncology and immunotherapy pipeline updates, plus any strategic step that clarifies what still has value.
What future catalysts are investors watching for Curis Inc?
Curis’s catalysts are oncology and immunotherapy pipeline updates, plus any strategic step that clarifies what still has value. The company needs a cleaner development path to matter again.